Bio

Interested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.

Clinical Focus

  • Psychedelic-assisted therapy
  • Ketamine
  • Psychiatry

Academic Appointments

  • Clinical Assistant Professor, Psychiatry and Behavioral Sciences

Honors & Awards

  • Trainee Innovator Grant Recipient, Stanford, Department of Psychiatry and Behavioral Science (2021)

Professional Education

  • Board Certification: American Board of Psychiatry and Neurology, Psychiatry (2023)
  • Residency: Stanford University Psychiatry and Behavioral Sciences (2023) CA
  • Medical Education: Warren Alpert Medical School Brown University (2019) RI
  • MD, Brown University, Medicine (2019)
  • BA, UC Berkeley, Interdisciplinary Studies (2014)

Contact

  • Academic
    gglick@stanford.edu
    University - Academic staff Department: Psych/General Psychiatry and Psychology (Adult) Position: Clinical Assistant Professor
  • Clinical (Primary)  Psychiatry Clinic 401 Quarry Rd MC 5718 Stanford, CA 94305 (650) 724-9900 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5717

2024-25 Courses

All Publications

  • What Is in a Name? The Many Meanings of “Psychedelic” Psychedelic Medicine O'Donnell, K., Glick, G., et al 2023

    View details for DOI 10.1089/psymed.2023.0011

  • Psychedelic-Assisted Group Therapy: A Systematic Review JOURNAL OF PSYCHOACTIVE DRUGS Trope, A., Anderson, B. T., Hooker, A. R., Glick, G., Stauffer, C., Woolley, J. D. 2019; 51 (2): 174-188

    Abstract

    Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation. Several recent reviews that highlight the contributions of this early literature have focused on psychedelic-assisted individual psychotherapy modalities. None have attempted to systematically identify and compile experimental studies of psychedelic-assisted group therapy. In therapeutic settings, psychedelics were often used to enhance group therapy for a variety of populations and clinical indications. We report on the results of a systematic review of the published literature in English and Spanish on psychedelic-assisted group therapies. Publications are characterized by their clinical approach, experimental method, and clinical outcomes. Given the renewed interest in the clinical use of psychedelic medicines, this review aims to stimulate hypotheses to be tested in future research on psychedelic-assisted psychotherapy, group process, and interpersonal functioning.

    View details for DOI 10.1080/02791072.2019.1593559

    View details for Web of Science ID 000465678000001

    View details for PubMedID 30950777

    View details for PubMedCentralID PMC6650145